In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at ...

If you’re retiring soon or know someone who is, you’re not alone. In 2024, a record 4.1 million Americans are expected to retire, with over 11,000 turning 65 every day. This phenomenon is sometimes re ...

The Federal Trade Commission filed an action against the three largest prescription drug benefit managers or PBMs— CVS Health's ...

Medicare Advantage denials. Medicare Advantage plans, which are private insurance plans that contract with Medicare, denied 3 ...

The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...

The FTC filed a lawsuit on Friday, alleging three largest pharmacy benefit managers “artificially" inflated the cost of ...

On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...

Hires in the realm of technology innovation and operations also feature, along with a pair of additions to boards of ...

Rossen Reports looked at the FTC data so far in 2024. Read the full story here. Millions of us have memberships to wholesale ...

FTC sues top PBMs for inflating insulin prices, accusing them of rigging competition and hurting patients. Legal action also includes GPOs.

The Federal Trade Commission has accused three major pharmacy benefit managers of inflating insulin prices, the agency said ...

This was the stock's second consecutive day of losses.